No abstract available.
Neuralgia*

We conducted a hospital based study to collect data on the clinical characteristics of neuropathic pain (NP) patients in neurology outpatients in 13 big cities in Indonesia. We aimed to identify the clinical characteristics of NP among patients with the symptoms of pain. A simple questionnaire was conducted to explore the clinical symptoms and signs. Participants who reported of NP symptom was 1,779 (21.8%) among 8,160 patients. The higher prevalence of NP was reported in 41-60 years old (n= 1,030; 57.9%). It was more prevalent in male (n=1,104; 62.1%). The group of patients with low educational level has higher prevalence of pain with NP (n=1,177; 66.1%). There are five main clinical symptoms of NP patients, pinprick sensation (n=589; 33.1%), electric shock like sensation (n=542, 30.5%), burning (n=407, 22.9%), paresthesia (n=401; 22.5%) and hyperalgesia (n=351, 19.7%). In this study, NP was mostly associated with low back pain (n=509, 28,6%), carpal tunnel syndrome (n=343; 19.3%), frozen shoulder syndrome (n=191, 10.7%), diabetic neuropathy (n=170, 9.6%) and brachialgia (n=108, 6.1%). The most frequent modality to treat NP symptoms were adjuvant analgesics, antidepressants or anticonvulsants (n=1,199; 67.4%), non-steroidal anti-inflammatory drugs (n=1,177, 66.2%), non-opioids analgesics (n=606; 34.1%), non-pharmacological treatment (n=366; 20.6%) and opioid treatments (n=100, 5.6%).
Neuralgia

No abstract available.
Autophagy* ; Neuralgia*

No abstract available.
Nefopam* ; Neuralgia*

No abstract available.
Neuralgia, Postherpetic*

No abstract available.
Myelitis* ; Neuralgia*

No abstract available.
Neuralgia, Postherpetic*

No abstract available.
Trigeminal Neuralgia

Humans ; Neuralgia

BACKGROUND: The lidocaine patch has been effectively used as a first-line therapy to treat neuropathic pain such as postherpetic neuralgia (PHN). OBJECTIVE: To evaluate the safety and efficacy of the topical piroxicam patch as a treatment option for the treatment of PHN. METHODS: Eighteen patients completed a 3-session study, applying three different patches (lidocaine, piroxicam and control) in random order. A maximum of three patches were applied to the most painful area for three consecutive days (12 hours on followed by 12 hours off). Each session was conducted at least seven days apart. The changes in visual analog scale (VAS) scores based pain intensity, quality of sleep and adverse effects were recorded. RESULTS: When compared to the control, both the lidocaine and piroxicam patches significantly reduced the mean VAS scores of pain intensity of all different types. However, the lidocaine patch was better at reducing allodynia, whereas the piroxicam patch was more effective for dull pain. The lidocaine patch worked faster than the piroxicam patch for the response to overall pain relief. CONCLUSION: The results of this study suggest the use of the piroxicam patch for dull pain and in patients where the lidocaine patch is contraindicated.
Humans ; Hyperalgesia ; Lidocaine ; Neuralgia ; Neuralgia, Postherpetic ; Piroxicam